Skip to main content
Skip to main content
THC logo

Tenet Healthcare Corporation (THC)

$206.91 +$3.19 (+1.56%) |Exceptional · 84
Signals are mixed — the Council read leans BUY (74/100) while the AI fundamental score is 84/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Seth Klarman bullish.
MCap: $17.82B| P/E Ratio: 9.5| Vol: 613.8K| Target: $240.50 (+16.2%)| 52-wk range: $146.60 – $247.21
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Tenet Healthcare Corporation (THC) trades at $206.91 with AI Score 84/100 (Grade A+). Tenet Healthcare Corporation operates a diversified healthcare services business, including hospitals, ambulatory care centers, and healthcare business process services. Market cap: $17.82B, Sector: Healthcare.

Price live · AI analysis from May 10, 2026
Tenet Healthcare Corporation operates a diversified healthcare services business, including hospitals, ambulatory care centers, and healthcare business process services. The company operates 60 hospitals and approximately 550 other healthcare facilities.

THC stock analysis for 2026: Analysts have set a consensus price target of $240.50 for Tenet Healthcare Corporation, suggesting 16.2% upside from the current price of $206.91. The AI MoonshotScore is 84/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 74/100 · A

THC: 5/7 perspectives are bullish. Dominant signal: Seth Klarman bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bullish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

Tenet Healthcare Corporation (THC) Healthcare & Pipeline Overview

CEOSaumya Sutaria
Employees98000
HeadquartersDallas, TX, US
IPO Year1980

Tenet Healthcare Corporation, a diversified healthcare services company, operates hospitals and ambulatory care centers, providing acute care, outpatient services, and healthcare business process solutions. With a $17.82B market cap and a P/E ratio of 9.5, Tenet focuses on expanding its network and optimizing revenue cycle management.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 10, 2026

What Is the Investment Thesis for THC?

Tenet Healthcare Corporation presents a compelling investment case driven by its diversified service offerings and strategic market positioning. With a market capitalization of $17.82B and a P/E ratio of 9.5, Tenet demonstrates financial stability and growth potential. The company's focus on expanding its ambulatory care segment and optimizing its healthcare business process services through Conifer are key value drivers. A profit margin of 7.9% and gross margin of 42.8% indicate efficient operations. Upcoming catalysts include further expansion of ambulatory surgery centers and enhanced revenue cycle management solutions. Potential risks include regulatory changes and increasing competition in the healthcare services market. Investors should monitor these factors to assess the long-term viability of Tenet's growth strategy.

Based on FMP financials and quantitative analysis

THC Key Highlights

  • Market Cap of $17.82B indicates substantial investor confidence and company size.
  • P/E ratio of 9.5 suggests the company may be undervalued compared to its earnings.
  • Profit Margin of 7.9% demonstrates the company's ability to generate profit from its revenue.
  • Gross Margin of 42.8% reflects efficient cost management in providing healthcare services.
  • Beta of 1.50 indicates the stock is more volatile than the market, potentially offering higher returns but also higher risk.

Who Are THC's Competitors?

THC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
HCA HCA Healthcare, Inc. $415.66 +1.26% $92.21B 86
EHC Encompass Health Corporation $107.03 +0.54% $10.62B 87
ENSG The Ensign Group, Inc. $167.34 -0.53% $9.78B 76
DVA DaVita Inc. $233.77 -0.49% $15.00B 88
UHS Universal Health Services, Inc. $158.44 +0.07% $9.92B 90
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
SLHGP Skylight Health Group Inc. $12.00 -5.88% 61

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are THC's Key Strengths?

  • Diversified healthcare services offerings.
  • Extensive network of hospitals and ambulatory care centers.
  • Established healthcare business process services segment.
  • Strong relationships with payers and providers.

What Are THC's Weaknesses?

  • High debt levels.
  • Exposure to regulatory changes and reimbursement pressures.
  • Dependence on government programs (Medicare/Medicaid).
  • Operational challenges in managing a large and complex organization.

What Could Drive THC Stock Higher?

  • Expansion of ambulatory care network to increase outpatient service capacity.
  • Implementation of value-based care initiatives to improve patient outcomes and reduce costs.
  • Potential acquisitions of smaller healthcare providers to expand geographic reach.
  • Enhancement of healthcare business process services to drive revenue growth.
  • Integration of telemedicine and digital health solutions to improve patient access to care.

What Are the Key Risks for THC?

  • Insider selling — insiders were net sellers of roughly $1.8M recently.
  • Regulatory changes and reimbursement pressures impacting revenue.
  • Increasing competition in the healthcare services market.
  • Rising operating costs, including labor and supplies.
  • Cyberattacks and data breaches compromising patient data.
  • High debt levels impacting financial flexibility.

What Are the Growth Opportunities for THC?

  • Expansion of Ambulatory Care Services: Tenet has a significant opportunity to grow its ambulatory care segment, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers. The market for ambulatory surgery centers is projected to reach $47.5 billion by 2027, driven by increasing demand for outpatient procedures and technological advancements. By expanding its network of ambulatory care facilities, Tenet can capture a larger share of this growing market and improve patient access to convenient, cost-effective care. This expansion is expected to contribute significantly to revenue growth over the next 3-5 years.
  • Enhancement of Healthcare Business Process Services: Through its Conifer segment, Tenet offers healthcare business process services, including revenue cycle management, patient communications, and value-based care solutions. The market for healthcare business process outsourcing is expected to reach $111.4 billion by 2028, driven by the need for healthcare providers to improve efficiency and reduce costs. By enhancing its service offerings and expanding its customer base, Tenet can capitalize on this growing market and generate recurring revenue streams. This is an ongoing opportunity with continuous improvements expected.
  • Strategic Acquisitions and Partnerships: Tenet can pursue strategic acquisitions and partnerships to expand its geographic reach and service offerings. The healthcare industry is consolidating, creating opportunities for companies to acquire smaller players and integrate their operations. By acquiring or partnering with complementary businesses, Tenet can strengthen its market position and enhance its competitive advantage. This is an ongoing strategy with potential acquisitions evaluated regularly.
  • Telemedicine and Digital Health Solutions: The increasing adoption of telemedicine and digital health solutions presents a significant growth opportunity for Tenet. The telemedicine market is projected to reach $460 billion by 2030, driven by increasing demand for remote healthcare services and technological advancements. By integrating telemedicine and digital health solutions into its service offerings, Tenet can improve patient access to care, enhance patient engagement, and reduce costs. This is an ongoing opportunity with continuous technology integration.
  • Focus on Value-Based Care: As the healthcare industry shifts towards value-based care models, Tenet has an opportunity to focus on improving patient outcomes and reducing costs. Value-based care models reward healthcare providers for delivering high-quality, cost-effective care. By implementing value-based care initiatives, Tenet can improve its financial performance and enhance its reputation as a leading healthcare provider. This is an ongoing opportunity with continuous quality improvement programs.

What Opportunities Does THC Have?

  • Expansion of ambulatory care services.
  • Strategic acquisitions and partnerships.
  • Growth in telemedicine and digital health solutions.
  • Focus on value-based care models.

What Threats Does THC Face?

  • Increasing competition in the healthcare services market.
  • Rising operating costs, including labor and supplies.
  • Potential for cyberattacks and data breaches.
  • Changes in healthcare policy and regulations.

What Are THC's Competitive Advantages?

  • Scale and geographic presence: Operates a large network of hospitals and ambulatory care centers.
  • Diversified service offerings: Provides a wide range of healthcare services across multiple segments.
  • Healthcare business process services: Offers specialized services that are difficult to replicate.
  • Established relationships with payers: Has long-standing relationships with insurance companies and government programs.

What Does THC Do?

Tenet Healthcare Corporation, incorporated in 1975 and headquartered in Dallas, Texas, has evolved into a diversified healthcare services provider. The company operates through three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer a wide array of services, including acute care, operating and recovery rooms, radiology and respiratory therapy, clinical laboratories, and pharmacies. They also provide intensive and critical care, coronary care units, and specialized services in cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics. Tenet also delivers outpatient services, such as physical therapy, and advanced procedures like cardiothoracic and complex spinal surgery. The company's ambulatory care segment includes surgery and urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Through Conifer, Tenet offers healthcare business process services, including revenue cycle management, patient communications, and value-based care solutions, serving hospitals, health systems, physician practices, and employers. As of February 2022, Tenet operated 60 hospitals and approximately 550 other healthcare facilities.

What Products and Services Does THC Offer?

  • Operates general hospitals offering acute care services.
  • Provides operating and recovery rooms for surgical procedures.
  • Offers radiology and respiratory therapy services.
  • Manages clinical laboratories and pharmacies within its hospitals.
  • Provides intensive and critical care units for seriously ill patients.
  • Operates ambulatory surgery and urgent care centers.
  • Offers healthcare business process services, including revenue cycle management.
  • Manages patient communications and engagement support.

How Does THC Make Money?

  • Generates revenue from hospital operations, including inpatient and outpatient services.
  • Earns fees from ambulatory care services, such as surgery and urgent care centers.
  • Provides healthcare business process services to hospitals and physician practices.
  • Receives payments from insurance companies, government programs (Medicare/Medicaid), and patients.

What Industry Does THC Operate In?

Tenet Healthcare operates within the medical care facilities industry, which is experiencing growth due to an aging population and increasing demand for healthcare services. The industry is characterized by a mix of large hospital chains and smaller independent facilities. Tenet competes with companies like HCA Healthcare, Inc. and Universal Health Services, Inc., focusing on expanding its ambulatory care services to capture a larger share of the outpatient market. The industry is also facing challenges related to regulatory changes, reimbursement pressures, and rising operating costs.

Who Are THC's Key Customers?

  • Patients seeking acute care and specialized medical services.
  • Hospitals and health systems requiring business process services.
  • Physician practices needing revenue cycle management solutions.
  • Employers seeking value-based care solutions for their employees.
AI Confidence: 73% Updated: May 10, 2026

ROE 41%Key Financial Metrics

Return on equity for Tenet Healthcare Corporation stands at 40.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.5%, showing how much profit it generates from its asset base. THC trades at a trailing price-to-earnings ratio of 9.51, below the Healthcare sector average of ~23x. Its free cash flow yield is 19.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.36 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 9.6%, the inverse of the P/E and a quick read on earnings relative to price.

Tenet Healthcare Corporation (THC) Valuation Context

Valued at $17.82B, THC is classified as a large-cap stock. Relative to its peer group, THC's quantitative score of 84/100 is roughly in line with the peer average of 85/100.

Company Profile

Tenet Healthcare Corporation operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Dallas, US. The company is led by CEO Saumya Sutaria. THC has traded publicly since 1980.

F-Score 6/9Financial Health

Tenet Healthcare Corporation's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.89 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project Tenet Healthcare Corporation revenue of about $21.98B for fiscal 2026, with EPS near $17.94. The estimate reflects 15 contributing analysts.

Net buyingInsider Activity

Over the past six months, Tenet Healthcare Corporation insiders filed 30 SEC Form 4 transactions — 14 sales and 16 purchases. On net that is roughly 3K shares acquired (about $1.8M) — insiders putting money in tends to read as conviction.

THC Financials

Fundamental Snapshot

Revenue Growth (FY)
+3.1%
Net Income Growth (FY)
-56.0%
EPS Growth (FY)
-52.7%
Free Cash Flow Growth (FY)
+126.7%
P/E (TTM)
10.4
Return on Equity (TTM)
+40.6%
Current Ratio
1.4
EV/EBITDA (TTM)
5.7

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in the company's future, indicating that executives believe in a turnaround.
  • Community sentiment has shifted positively, with increased discussions around Tenet's strategic initiatives in expanding service offerings.
  • Analysts highlight the potential for growth in the healthcare sector, especially with rising demand for healthcare services post-pandemic.
  • Tenet's recent partnerships and acquisitions are seen as a way to enhance its market position and drive revenue growth.

Bear Case

  • Concerns about operational challenges persist, as some investors worry about the sustainability of profitability amid rising costs.
  • Negative community sentiment has emerged regarding regulatory pressures and potential changes in healthcare policies that could impact margins.
  • Recent earnings reports have raised questions about the effectiveness of management's strategies, leading to skepticism among investors.
  • Market perception remains cautious due to historical volatility in the healthcare sector, as seen during previous downturns like the 2008 financial crisis.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

THC Latest News

THC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for THC.

Price Targets

Consensus target: $240.50

THC MoonshotScore

84/100

What does this score mean?

The MoonshotScore rates THC's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Saumya Sutaria

CEO

Saumya Sutaria is the CEO of Tenet Healthcare Corporation, managing a workforce of 98,000 employees. His background includes extensive experience in the healthcare industry. He has held various leadership positions, demonstrating expertise in strategic planning, operational management, and financial performance. Sutaria's career reflects a commitment to innovation and improving healthcare delivery.

Track Record: Under Saumya Sutaria's leadership, Tenet Healthcare has focused on expanding its ambulatory care services and enhancing its healthcare business process solutions. Key achievements include improving operational efficiency and driving revenue growth. Strategic decisions have centered on optimizing the company's portfolio and investing in technology to enhance patient care and streamline operations.

What Investors Ask About Tenet Healthcare Corporation (THC) — Healthcare

What does Tenet Healthcare Corporation do?

Tenet Healthcare Corporation operates as a diversified healthcare services company, primarily focusing on hospital operations, ambulatory care, and healthcare business process services. The company manages 60 hospitals and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care centers, and imaging centers. Through its Conifer segment, Tenet offers revenue cycle management, patient communications, and value-based care solutions to hospitals, health systems, and physician practices, positioning itself as a comprehensive healthcare solutions provider.

What do analysts say about THC stock?

Analyst consensus on Tenet Healthcare Corporation (THC) generally reflects a positive outlook, driven by the company's diversified service offerings and strategic growth initiatives. Key valuation metrics, such as the P/E ratio of 9.5, suggest potential undervaluation compared to its earnings. Growth considerations include the expansion of ambulatory care services and the enhancement of healthcare business process solutions. Analysts closely monitor regulatory changes and competitive pressures within the healthcare industry, but overall, the sentiment leans towards continued growth and financial stability for Tenet.

What are the main risks for THC?

Tenet Healthcare Corporation faces several key risks, including regulatory changes impacting reimbursement rates and operational compliance. Increasing competition in the healthcare services market could erode market share and profitability. Rising operating costs, particularly labor and supply expenses, pose a threat to margins. The potential for cyberattacks and data breaches could compromise patient data and result in significant financial and reputational damage. Additionally, high debt levels may limit financial flexibility and increase vulnerability to economic downturns. These factors require careful monitoring to assess the long-term viability of Tenet's business model.

What are the key factors to evaluate for THC?

Tenet Healthcare Corporation (THC) holds an AI score of 84/100 (high). P/E: 9.5x vs the S&P 500's ~20-25x. Analysts target $240.50 (+16%). Not financial advice.

How frequently does THC data refresh on this page?

THC prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven THC's recent stock price performance?

Tenet Healthcare Corporation (THC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified healthcare services offerings. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider THC overvalued or undervalued right now?

Tenet Healthcare Corporation (THC) trades at 9.5x earnings. Analysts target $240.50 (+16%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

What research should beginners do before buying THC?

Before investing in Tenet Healthcare Corporation (THC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data as of 2026-05-10.
  • Financial metrics are based on the most recent available reports.
  • Industry trends and market projections are based on third-party research and analysis.
Data Sources

Popular Stocks